Global Immune Repertoire Sequencing Market Revenue Grows at a CAGR of 10.28%

Straits Research released its highly anticipated report, “Global Immune Repertoire Sequencing Market Size & Outlook, 2026-2034”. According to the study, the market size is valued at USD 362.96 million in 2025 and is anticipated to grow to USD 872.66 million by 2034, growing at a CAGR of 10.28% from 2026-2034.

Market Dynamics

The immune repertoire sequencing market is driven by rising adoption of detailed T cell and B cell profiling in oncology, infectious disease monitoring, and cell therapy development, as research groups and biopharma companies increasingly rely on receptor level insights to guide therapy evaluation and biomarker discovery. The market faces restraint due to limited availability of diverse reference datasets and the technical complexity associated with interpreting large scale immune sequencing outputs, which creates barriers for laboratories with constrained computational capacity or limited access to trained personnel. Despite these challenges, the market presents a growing opportunity through the expansion of regional immunology data networks and multi institutional collaborations that aim to standardize immune profiling workflows, broaden population level datasets, and encourage uptake of advanced sequencing platforms and bioinformatics solutions across research and clinical ecosystems.

Market Highlights

• Product Type: The reagents and kits segment dominated the market with a revenue share of 43.42% in 2025.
• Application: The oncology and cancer immunotherapy segment dominated the market with a 39.43% share in 2025.
• End User: The academic and research institutes segment dominated the market with a 48.98% share in 2025.
• Regional Insights: North America held a dominant share of the global market, accounting for 45.13% share in 2025.

Market Segments

1. By Product Type (2026-2034)
   1. Reagents & Kits
      1. DNA Extraction Kits
      2. RNA Extraction Kits
      3. Library Preparation Kits
      4. Target Enrichment Kits
      5. PCR Amplification Kits
      6. Others
   2. Sequencing Platforms
      1. Illumina Platforms 
      2. Oxford Nanopore
      3. PacBio Systems
      4. Others
   3. Software & Services
      1. Data Analysis Software
      2. Bioinformatics Services
      3. Cloud-Based Platforms
      4. Custom Sequencing Services
      5. Others
2. By Application (2026-2034)
   1. Oncology & Cancer Immunotherapy
   2. Autoimmune & Inflammatory Diseases
   3. Infectious Diseases & Vaccine Development
   4. Transplantation & Immune Tolerance
   5. Others
3. By End User (2026-2034)
   1. Pharmaceutical & Biotechnology Companies
   2. Academic & Research Institutes
   3. Hospitals & Clinical Labs
   4. Contract Research Organizations (CROs)
   5. Government & Regulatory Bodies
   6. Others